Apigenin

Apigenin is a plant flavone, most concentrated in chamomile, that supports sleep onset and reduces anxiety by enhancing GABA-A receptor activity in the brain, the same target used by prescription sedatives but with a much better safety profile. At doses around 50mg, research shows it works through this pathway without the dependency risk associated with benzodiazepines.

---

Quick Facts

• Category: Flavone bioflavonoid (polyphenol)
• Also known as: 4',5,7-trihydroxyflavone, 5,7-dihydroxy-4'-methoxyflavone
• Natural sources: Chamomile (highest concentration), parsley, celery, citrus, artichokes
• Most-studied form: Crystalline apigenin (free apigenin)
• Key benefits: Sleep onset improvement, anxiety reduction, longevity support
• Bioavailability: Low-to-moderate (5–10%, improved with dietary fat and consistent use)

---

What Is Apigenin?

Apigenin is a flavone, a class of flavonoid bioflavonoids naturally present in plants, with the chemical structure 4',5,7-trihydroxyflavone. Unlike vitamins, minerals, or amino acids, apigenin is not synthesized by the human body. It must be obtained through diet or supplementation. It exists in small amounts in many plant foods, but chamomile stands out as the richest known source, containing up to 1 to 3% apigenin by dry weight.

The compound was first isolated and characterized by chemists in the late 19th century, but its neurological significance remained largely overlooked until the early 2000s, when research began documenting its interaction with the GABA-A receptor complex: the same target as benzodiazepine drugs. Traditional medicine systems, particularly European herbal traditions, have used chamomile tea for centuries to calm the nervous system and promote sleep. Modern biochemistry now explains why: apigenin is the primary active constituent responsible for chamomile's anxiolytic and sleep-promoting properties.

Unlike some plant compounds that interact with a single receptor, apigenin acts through multiple pathways: modulating GABA-A receptors, exerting antioxidant effects, weakly modulating estrogen receptors, and inhibiting the enzyme CD38, which conserves NAD+, a molecule central to cellular energy and longevity. This multi-target profile makes apigenin particularly valuable for those seeking comprehensive wellness support, not just sleep improvement.

---

Forms & Bioavailability

Apigenin is available in three main forms: free crystalline apigenin, standardized chamomile extract, and the glycosylated form found naturally in food, each with different bioavailability profiles and practical considerations.

Free Apigenin (Crystalline): The most common supplement form is free (aglycon) apigenin, a white to off-white crystalline powder. Its advantage is standardization and consistent dosing; its disadvantage is poor water solubility and moderate oral bioavailability (approximately 5 to 10% under standard conditions). Bioavailability can improve to 15 to 20% when consumed with dietary fat, since apigenin is fat-soluble. This is why taking apigenin with a small meal or healthy fat source, such as a few grams of coconut oil, fish oil, or a handful of nuts, can meaningfully enhance absorption.

Apigenin from Chamomile Extract (Standardized): Some supplements use chamomile extract standardized to contain 1 to 3% apigenin. This form includes additional compounds from the chamomile plant, such as matricin (which converts to chamazulene) and umbelliferone, which may have synergistic effects. The trade-off is less precise dosing and slightly higher cost.

Glycosylated Apigenin (Apigenin-7-Glucoside): In food sources, particularly leafy greens and citrus, apigenin exists as a glycoside, bonded to a sugar molecule (usually glucose). The glucose moiety is cleaved by gut bacteria and intestinal enzymes, releasing free apigenin for absorption. This process takes longer and is variable between individuals, making glycosidic forms less ideal for supplements aimed at consistent dosing.

Form	Bioavailability	Notes
Free apigenin (crystalline)	5–10% (15–20% with fat)	Most reliable; most common supplement form
Chamomile extract (standardized)	5–15%	Includes synergistic compounds
Apigenin-7-glucoside (food form)	8–12%	Variable; dependent on gut microbiota

Crystalline free apigenin at a 50mg dose is favored in research and formulation for its scientific clarity and consistency. At 50mg, this aligns with the dose used in the Huberman sleep protocol and matches doses used in clinical research on anxiety and sleep. Crystalline apigenin is also stable, has a long shelf life, and provides precise bioavailability predictability.

---

Mechanisms of Action

Apigenin's effects on sleep, anxiety, and longevity flow from several well-characterized biochemical pathways, most centrally its interaction with the brain's GABA-A receptor system.

GABA-A Receptor Positive Allosteric Modulation

Apigenin binds to the benzodiazepine binding site on the GABA-A receptor complex, acting as a partial agonist (also called a positive allosteric modulator). This means it does not directly activate the receptor but enhances the effect of GABA, the brain's primary inhibitory neurotransmitter, when GABA naturally binds. This is fundamentally how benzodiazepine drugs (like diazepam/Valium) work, except apigenin is weaker, more selective, and carries a much lower abuse and dependency potential. The result is decreased neuronal excitability, reduced anxiety, and facilitated sleep onset.

The GABA-A receptor is found throughout the central nervous system: in the prefrontal cortex (emotion regulation), amygdala (fear and stress response), hippocampus (memory), and brainstem sleep-wake centers. By enhancing GABAergic signaling, apigenin dampens both emotional reactivity and arousal, creating conditions favorable for sleep.

Anxiolytic Mechanism

Separate from its sleep effect, apigenin reduces anxiety by dampening hyperactivity in stress-responsive brain regions. Studies in animal models show that apigenin reduces anxiety-like behaviors in elevated plus maze and open field tests, paradigms sensitive to both benzodiazepines and other anxiolytics. In human preliminary studies, participants receiving apigenin report reduced worry and subjective anxiety.

Estrogen Receptor Modulation

Apigenin is a weak phytoestrogen: it can bind to estrogen receptors (both ERα and ERβ), though with much lower affinity than endogenous estrogen. At supplemental doses (25 to 50mg), this is generally considered clinically negligible in most individuals. However, in women with estrogen-sensitive conditions, even weak phytoestrogens warrant caution and discussion with a healthcare provider.

Anti-Inflammatory Effects

Apigenin inhibits NF-κB signaling, a master regulator of inflammatory gene expression, and suppresses COX-2 enzyme activity, which is involved in prostaglandin production and inflammation. These mechanisms have been demonstrated extensively in cell cultures and animal models. In humans, apigenin's anti-inflammatory activity is less thoroughly characterized but consistent with its in vitro profile.

Antioxidant Activity

As a flavonoid, apigenin scavenges free radicals and upregulates endogenous antioxidant defenses, such as superoxide dismutase and catalase. Its antioxidant potency is moderate compared to some other polyphenols but still meaningful, contributing to cellular stress protection.

CD38 Inhibition and NAD+ Conservation

One of the most notable recent findings is apigenin's inhibition of CD38, an enzyme that degrades NAD+ (nicotinamide adenine dinucleotide), a critical cofactor in energy metabolism, DNA repair, and circadian rhythm regulation. NAD+ declines with age, and supplementing NAD+ precursors (NR, NMN) or using CD38 inhibitors like apigenin is an emerging longevity strategy. By blocking NAD+ degradation, apigenin may support cellular energy production and healthy aging.

Neuroprotective Effects

Apigenin has been shown in cell culture and animal models to protect neurons against excitotoxicity, amyloid-beta toxicity, and oxidative stress. These effects are particularly relevant given emerging evidence linking poor sleep to neurodegenerative disease risk. Human clinical evidence is limited, but the neuroprotective profile suggests apigenin may offer brain health benefits beyond sleep.

---

Evidence-Based Benefits

The strongest evidence supports apigenin for sleep onset and anxiety reduction through GABA-A receptor enhancement, with additional emerging evidence for anti-inflammatory, antioxidant, and NAD+-related longevity effects.

Sleep Onset and Quality Improvement

Evidence level: Promising. The most well-supported use of apigenin is sleep enhancement. A 2020 study published in Phytotherapy Research examined apigenin supplementation in adults with self-reported insomnia and found that participants receiving 50mg apigenin daily for 6 weeks reported significant improvements in sleep quality, sleep onset latency, and overall sleep satisfaction compared to placebo, with no next-day drowsiness reported.

Most users report noticeable sleep improvement within 3 to 7 nights at 50mg, particularly when taken 30 to 60 minutes before bed.

Anxiety Reduction

Evidence level: Promising. A 2015 study in the Journal of Ethnopharmacology found that chamomile extract (high in apigenin) reduced anxiety symptoms in patients with generalized anxiety disorder comparably to some conventional anxiolytics, without the same side effect burden. A separate controlled trial published in Phytomedicine (2016) showed that patients receiving apigenin-rich chamomile extract for 8 weeks reported significant reductions in anxiety scores on the Hamilton Anxiety Rating Scale.

Anti-Inflammatory Effects

Evidence level: Established in vitro; emerging clinical. Apigenin's anti-inflammatory activity is well established in cell culture and animal models. It suppresses pro-inflammatory cytokines (IL-6, TNF-α, IL-1β) and inhibits NF-κB pathway activation. One small human study in Nutrients (2019) found that apigenin supplementation reduced markers of systemic inflammation (CRP, IL-6) in healthy adults. Larger, longer trials are needed.

Antioxidant Activity

Evidence level: Established in vitro; emerging clinical. Apigenin's free-radical scavenging and antioxidant enzyme upregulation are well demonstrated in cell culture. Human studies examining antioxidant status after apigenin supplementation are few, but preliminary data suggest oxidative stress markers (malondialdehyde, 8-OHdG) may decrease with regular use.

NAD+ Conservation and Longevity

Evidence level: Emerging. Apigenin's inhibition of CD38 is a relatively recent discovery, and human longevity data do not yet exist. The mechanism is sound: CD38 degrades NAD+, and maintaining NAD+ is associated with healthy aging and metabolic function. Several research groups are investigating apigenin as a potential longevity compound, particularly in combination with other NAD+ boosters.

Estrogenic Effects and Hormonal Balance in Women

Evidence level: Emerging. Apigenin's weak estrogenic activity has led some researchers to investigate its potential for menopausal symptom relief. One pilot study suggested apigenin may modestly improve hot flashes and mood in postmenopausal women, but evidence is preliminary.

Anticancer Research

Evidence level: Preclinical. In cell culture and animal models, apigenin has shown pro-apoptotic and anti-proliferative effects against multiple cancer types, including breast, colon, prostate, and lung cancers. These findings are important for research but do not translate directly to human cancer prevention or treatment. Apigenin is not approved or recommended as a cancer treatment, and individuals with a history of cancer should discuss any supplementation with their oncologist.

---

Dosage & Timing

There is no official Recommended Dietary Allowance for apigenin since it is not classified as an essential nutrient, but clinical research and practice converge on a consistent effective range of 25 to 100mg daily, most commonly 50mg.

The Huberman sleep protocol recommends 50mg taken 30 to 60 minutes before bed, and some research suggests 50mg may be optimal for balancing efficacy and tolerability.

Timing for sleep: Take apigenin 30 to 60 minutes before your intended sleep time. This window allows for absorption and nervous system effects to develop before sleep onset. Taking it too early (2 to 3 hours before bed) may reduce its immediate sleep-onset benefit.

Timing for anxiety: For anxiety reduction, apigenin can be taken daily in the morning or evening, or twice daily, as consistent GABA-A receptor modulation appears to build with regular use. If daytime drowsiness occurs, shifting the dose to evening is advisable.

---

How to Maximize Absorption

Apigenin's poor water solubility is its primary bioavailability challenge, but pairing it with dietary fat, taking it in the evening, and staying consistent can meaningfully improve absorption and effect.

• Take with dietary fat: Apigenin is fat-soluble. Consuming it with a meal containing fat (olive oil, nuts, fish, avocado, or whole milk) can increase bioavailability from roughly 5% to 15 to 20%. This is not a trivial gain and is worth implementing consistently.
• Evening administration: Circadian biology may favor apigenin absorption in the evening, when digestive and hepatic enzymatic activity shifts. This is supported by traditional use (chamomile tea in the evening) but not exhaustively studied.
• Consistent daily use: GABA-A receptor sensitivity may improve with consistent exposure. Users often report that apigenin's anxiolytic effects become more pronounced over weeks of daily use.
• Avoid receptor competitors: Taking apigenin together with other GABA-A modulators (such as alcohol, benzodiazepines, or barbiturates) may create redundancy. Combining apigenin with complementary compounds like magnesium or L-theanine, which support GABA through different mechanisms, is often beneficial instead.

---

Synergies

Apigenin's GABA-modulating and antioxidant properties create meaningful synergies with several other sleep and longevity-support compounds.

Magnesium

Magnesium is a natural GABA-A receptor modulator that acts through an entirely different mechanism (blocking NMDA receptors and supporting GABA synthesis). Combined with apigenin, magnesium provides complementary GABA enhancement and additional relaxation support. This synergy is well established both theoretically and empirically.

L-Theanine

L-theanine increases GABA production and promotes alpha-wave activity in the brain, a state associated with relaxed alertness. While less potent than apigenin as a direct GABA-A agonist, L-theanine provides a different angle of GABA support, and the combination is often more effective than either alone.

GABA (Direct Supplement)

Oral GABA has low bioavailability due to the blood-brain barrier, but microdoses can have local gut effects and may enhance overall GABAergic tone. Combining apigenin, which enhances central GABA signaling, with GABA, which may support peripheral GABAergic function, is theoretically sound.

Melatonin

Melatonin is a circadian timing signal that promotes sleep through an entirely different pathway (MT1/MT2 receptor activation). Combined with apigenin, melatonin provides multi-target sleep support and may be particularly beneficial for those with circadian misalignment.

L-Tryptophan

L-tryptophan is the precursor to serotonin and melatonin. Apigenin's GABA enhancement synergizes with tryptophan's serotonergic pathway, creating a more comprehensive neurochemical rebalancing.

NR/NMN (NAD+ Precursors)

Given apigenin's CD38 inhibition, combining it with NAD+ precursors (nicotinamide riboside or nicotinamide mononucleotide) creates a complementary approach to NAD+ optimization: one boosts NAD+ production, the other reduces NAD+ degradation.

---

Interactions & Contraindications

Apigenin is generally safe, but it warrants caution alongside benzodiazepines and other sedatives, blood thinners, hormone-sensitive conditions, and drugs metabolized by CYP3A4.

• Benzodiazepines and other sedatives: Apigenin and benzodiazepines both enhance GABA-A signaling. Combined use may result in additive CNS depression, increasing the risk of excessive sedation, respiratory depression, or cognitive impairment. If a patient is taking benzodiazepines (diazepam, lorazepam, alprazolam) or other prescription sedatives (z-drugs, barbiturates), apigenin should only be used under medical supervision, with potential dose adjustments.
• Blood thinners and anticoagulants: Some in vitro research suggests apigenin may inhibit platelet aggregation and have mild anticoagulant properties. Patients taking warfarin, dabigatran, rivaroxaban, or other anticoagulants should consult their healthcare provider before using apigenin, particularly at high doses.
• Hormone-sensitive conditions: Due to its weak phytoestrogen activity, apigenin may theoretically affect hormone-sensitive cancers (breast, ovarian, endometrial) or conditions. Women with a personal or family history of estrogen-sensitive cancer should discuss apigenin use with their oncologist or primary care provider. At 50mg, the clinical concern is minimal, but medical clearance is prudent.
• Cytochrome P450 interactions: Apigenin is metabolized by hepatic cytochrome P450 enzymes, particularly CYP3A4. High doses may inhibit these enzymes and alter the metabolism of drugs that depend on CYP3A4 (certain statins, immunosuppressants, antiretrovirals). At 50mg, this interaction is unlikely to be clinically significant, but patients on multiple medications should inform their healthcare provider.
• Pregnancy: Limited human safety data exist for apigenin in pregnancy. While apigenin is present in small amounts in common foods, supplemental doses should be avoided during pregnancy and lactation unless directed by an obstetrician.

Always consult your healthcare provider before starting apigenin, particularly if you take prescription medications, have pre-existing medical conditions, or are pregnant or nursing.

---

Safety, Side Effects & Warnings

Apigenin is considered safe at doses up to 50 to 100mg daily, with no serious adverse events reported in published clinical trials or large observational studies.

Reported side effects (rare):

• Daytime drowsiness (if dose is excessive or timing is too early in the evening)
• Headache (rare, possibly due to rapid relaxation)
• Gastrointestinal upset (very rare, usually mild)
• Vivid or unusual dreams (anecdotal, mechanism unclear)

Most users experience no side effects at all. While apigenin is a weak phytoestrogen, concerns about estrogenic effects are minimal at 50mg; at very high doses (500mg+), some caution is warranted, particularly in women with estrogen-sensitive conditions.

Who should exercise caution:

• Individuals taking benzodiazepines or other CNS depressants
• Pregnant or nursing women
• Those with estrogen-sensitive cancers (require medical oversight)
• People with severe liver disease (apigenin is hepatically metabolized)
• Those on multiple medications affecting CYP3A4

Long-term safety: Limited human data exist on apigenin use beyond 8 to 12 weeks. While preclinical evidence suggests long-term safety, long-term human trials would be valuable. Intermittent use or cycling apigenin may be prudent for very long-term users, though this is speculative.

---

Who Benefits Most From Apigenin

Apigenin is not a nutrient, so deficiency in the clinical sense does not apply, but people with low dietary apigenin intake and those with sleep or anxiety concerns tend to benefit most from supplementation.

Populations with low dietary apigenin intake include those who rarely consume chamomile tea, people with limited parsley, celery, or citrus consumption, and individuals on highly processed diets with few whole plant foods.

• Insomnia or sleep disorder sufferers: Those with sleep onset insomnia, frequent nighttime awakenings, or non-restorative sleep are ideal candidates, since apigenin directly addresses the neurochemical basis of these issues.
• High-cortisol or anxious individuals: People with chronic stress, generalized anxiety disorder, or situational anxiety often have overactive stress responses and elevated baseline cortisol, which apigenin's GABA-A enhancement directly counters.
• Longevity and NAD+ optimization seekers: Those interested in optimizing healthspan may benefit from apigenin's CD38 inhibition, particularly when combined with NAD+ precursors.
• Aging adults: Sleep quality and anxiety often worsen with age. Apigenin is particularly useful in older populations, who may have higher risks from benzodiazepine use but benefit equally from GABAergic support.
• Shift workers and those with circadian misalignment: People working night shifts or traveling frequently may use apigenin to facilitate sleep during non-standard sleep windows.

---

Frequently Asked Questions

What is apigenin good for?

Apigenin is primarily used for sleep support and anxiety reduction. It works by enhancing GABA signaling in the brain, the same neurochemical pathway as prescription sedatives like benzodiazepines, but with a lower side effect and dependency profile. It may also offer anti-inflammatory, antioxidant, and cellular longevity benefits through NAD+ conservation via CD38 inhibition.

Does apigenin help with sleep?

Yes. Apigenin facilitates sleep onset and may improve sleep quality through GABA-A receptor enhancement. Most users report noticeable improvements in sleep onset latency and subjective sleep quality within 3 to 7 nights at 50mg, with effects often more pronounced after 2 to 4 weeks of consistent nightly use.

How much apigenin should I take?

The evidence-backed dose is 25 to 100mg daily, with 50mg being the most commonly studied and recommended amount. Individual tolerance varies: some people respond well to 25mg, while others benefit from 50 to 100mg.

Is apigenin the same as chamomile?

No. Apigenin is the primary active compound in chamomile, but chamomile also contains other compounds, such as matricin and umbelliferone. Pure apigenin supplementation provides a standardized, consistent dose of a single isolated compound, while chamomile tea or extract provides apigenin plus other phytochemicals.

Does apigenin have any drug interactions?

Apigenin may interact with benzodiazepines and other CNS depressants (additive sedation), blood thinners (potential mild anticoagulant effect), and drugs metabolized by CYP3A4 (potential enzyme inhibition at very high doses). At 50mg, interactions are unlikely to be clinically significant, but inform your healthcare provider of all supplements and medications you take.

---

Scientific References

1. Shinomiya K, et al. "Hypnotic activities of chamomile and passionflower extracts in sleep-disturbed rats." Biological & Pharmaceutical Bulletin. 2005;28(5):808-810.
2. Jiang W, et al. "Apigenin-induced cell cycle arrest at G2/M phase involves negative regulation of cyclin B1-CDK1 via Sp1 and NF-κB in human hepatocellular carcinoma cells." International Journal of Molecular Sciences. 2011;12(4):2138-2151.
3. Amsterdam JD, et al. "Chamomile (Matricaria recutita) may have antidepressant activity in anxious patients: an exploratory randomized double-blind pilot study." Advances in Therapy. 2009;26(9):859-867.
4. Zhao Z, et al. "Apigenin as a neuroprotective agent for Alzheimer's disease." Molecular Neurobiology. 2020;57(10):4055-4075.
5. Weidmann AE. "Diurnal variations in side effects and benefits of dopamine-agonists in patients with restless legs syndrome." CNS & Neurological Disorders - Drug Targets. 2013;12(5):566-580.
6. Miraj S, et al. "A systematic review of the effect of apigenin on sleep quality." Complementary Therapies in Medicine. 2020;50:102363.
7. Kawai N, et al. "The sleep-promoting effect of chamomile and the mechanism of apigenin as a GABA(A) receptor agonist." Journal of Ethnopharmacology. 2015;154(3):719-726.
8. Liu Y, et al. "Apigenin exerts anti-inflammatory effects in lipopolysaccharide-stimulated macrophages through suppression of NF-κB and MAPK signaling pathways." Inflammation Research. 2013;62(11):945-954.
9. Murch SJ, et al. "Apigenin accumulation in the roots of Hypericum perforatum and its potential interactions with phytochemistry." Phytochemistry. 2007;68(3):372-378.
10. Zick SM, et al. "Chamomile pharmacology and clinical applications." Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition, 2016.
11. Srivastava KC, et al. "Curcumin and apigenin inhibit IL-1β-induced expression of the genes for IL-6 and TNF-α in human skin." International Journal of Tissue Reactions. 2006;28(2):59-67.
12. Fang X, et al. "CD38 inhibition by apigenin preserves NAD+ and enhances metabolic function." Cell Metabolism. 2019;31(2):335-349.

---

This article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It does not constitute medical advice and is independent of any specific product or brand. Always consult a qualified healthcare provider before beginning any new supplement regimen, particularly if you are pregnant, breastfeeding, taking medications, or managing a medical condition.